ORCHID PHARMA LIMITED

Other languages Orchid Pharma Limited

Equities

ORCHPHARMA

INE191A01027

Market Closed - NSE India S.E. Other stock markets 03:02:00 2024-05-18 am EDT			5-day change	1st Jan Change
1,075 ^INR	-1.68%		+5.94%	+50.89%

Apr. 12	Orchid Pharma Limited Announces Resignation of Mudit Tandon as Independent Director	CI
Feb. 23	Orchid Pharma Receives United States Food and Drug Administration Approval for Its Novel Invention	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Orchid Pharma Limited Announces Resignation of Mudit Tandon as Independent Director	Apr. 12
Orchid Pharma Receives United States Food and Drug Administration Approval for Its Novel Invention	Feb. 23
Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 08
European Medicines Agency Grants Approval for Orchid Pharma's 'Exblifep'	Jan. 30
Orchid Pharma Limited Appoints Kapil Dayya as Company Secretary & Compliance Officer	Dec. 16
Orchid Pharma Limited Announces Resignation of Marina Peter as Company Secretary and Compliance Officer	Dec. 14
Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 04
Orchid Pharma Limited Approves the Appointment of Mr. Arjun Dhanuka as Additional Director (In Capacity of Non-Executive & Non-Independent)	23-10-20
Orchid Pharma Limited Enters into Manufacturing Sub License Agreement with Global Antibiotic Research & Development Partnership	23-09-12
Orchid Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10
Orchid Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-10
Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-09
Orchid Pharma Limited Announces Demise of Arun Kumar Dhanuka, Non-Executive & Non-Independent Director	23-02-01
Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW